Pharmaceutical

5AM Ventures is a leading life science venture capital firm focused on funding and building next-generation life sciences companies. They primarily invest in early-stage private therapeutic companies, with an emphasis on Series A, and also invest in small and mid-cap public and later-stage private biotech and life science companies.

Aperture Venture Partners is a healthcare-focused investment firm committed to working with exceptional entrepreneurs to build innovative companies in the medical device, pharmaceutical, healthcare IT/services and diagnostic sectors. Our partners have deep industry knowledge and a track record of success in helping outstanding companies realize their potential.

Axil Capital is a venture capital firm specializing in biomedical and healthcare technology investments. They focus on supporting the growth of early-stage ventures and leveraging their global network to create synergies between the Japanese and global biotech ecosystems. Their investments span the full spectrum of the life science industry, from seed to crossover rounds.

Columbus Venture Partners invests in early-stage opportunities in the life science industry.

DAG Ventures is a mid-stage venture capital partnership focused on providing service-oriented support to visionary entrepreneurs and early-stage VCs. They lead mid-stage and growth financing rounds into promising portfolio companies. Their investment model emphasizes differentiation through superior service to LPs, portfolio companies, and early-stage VC partnerships.

Firstime Ventures invests in companies building a sustainable and accessible future. They focus on entrepreneurs with impactful products and clear business models, addressing urgent challenges like climate change and accessible healthcare. Their investment strategy aligns with the United Nations Sustainable Development Goals.

Fountain Healthcare Partners is a venture fund providing risk capital and expertise to life sciences companies. They focus on a limited number of portfolio companies to provide extensive support beyond capital, acting as true partners in growth and risk mitigation. Their investments span from seed stage to public offerings, with a majority in Europe and the remainder in the US.

Genesys Capital is a life science venture capital firm that invests in and builds early-stage companies in the high-growth sectors of biotechnology, pharmaceuticals, and medical technology. They have a proven track record of identifying emerging bioscience opportunities and transforming them into commercially successful enterprises.

Jeito Capital is a leading global investment company focused on biopharmaceuticals. They finance and accelerate cutting-edge medical innovation with a patient benefit approach, supporting entrepreneurs through significant capital contributions and expert guidance.

Lumira Ventures is a leading Canadian life sciences venture capital firm investing in and helping to create value in transformative life sciences companies. They focus on biotech, medtech, and healthcare companies transforming global healthcare through innovation, aiming for exceptional returns while delivering impact to patients.

PBM Capital is a healthcare-focused investment firm that invests in pharmaceutical and life sciences companies. They partner with scientists and entrepreneurs developing life-changing technologies, providing operational expertise and capital to build winning companies. PBM Capital has a history of successful IPOs from its portfolio companies.